Using the free-to-total prostate-specific antigen ratio to detect prostate cancer in men with nonspecific elevations of prostate-specific antigen levels

被引:0
|
作者
Richard M. Hoffman
David L. Clanon
Benjamin Littenberg
Joseph J. Frank
John C. Peirce
机构
[1] Albuquerque Department of Veterans Affairs Medical Center,the Medicine Service
[2] University of New Mexico School of Medicine,Department of Medicine
[3] The University of Vermont,the Department of Medical Education and Research
[4] Good Samaritan Regional Medical Center,undefined
[5] the Laboratory Sciences of Arizona,undefined
来源
关键词
prostatic neoplasm; prostate-specific antigen; diagnostic accuracy; free PSA;
D O I
暂无
中图分类号
学科分类号
摘要
BACKGROUND: Prostate-specific antigen (PSA) levels between 4.0 to 10.0 ng/ml have poor specificity in prostate cancer screening, leading to unnecessary biopsies.
引用
收藏
页码:739 / 748
页数:9
相关论文
共 50 条
  • [1] Using the free-to-total prostate-specific antigen ratio to detect prostate cancer in men with nonspecific elevations of prostate-specific antigen levels
    Hoffman, RM
    Clanon, DL
    Littenberg, B
    Frank, JJ
    Peirce, JC
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2000, 15 (10) : 739 - 748
  • [2] Activity does not affect free and total prostate-specific antigen levels but lowers the free-to-total prostate-specific antigen ratio
    Ulman, C
    Buyukyazi, G
    Taneli, F
    Uyanik, BS
    [J]. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2004, 32 (06) : 583 - 589
  • [3] Prostate-specific antigen adjusted for the transition zone volume versus free-to-total prostate-specific antigen ratio in predicting prostate cancer
    Moon, DG
    Cheon, J
    Kim, JJ
    Yoon, DK
    Koh, SK
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 1999, 6 (09) : 455 - 462
  • [4] Complexed prostate-specific antigen, complexed prostate-specific antigen density of total and transition zone, complexed/total prostate-specific antigen ratio, free-to-total prostate-specific antigen ratio, density of total and transition zone prostate-specific antigen: Results of the prospective multicenter European trial
    Djavan, B
    Remzi, M
    Zlotta, AR
    Ravery, V
    Hammerer, P
    Reissigl, A
    Dobronski, P
    Kaisary, A
    Marberger, M
    [J]. UROLOGY, 2002, 60 (4A) : 4 - 9
  • [5] Value of free-to-total prostate-specific antigen ratio for detection and staging of prostate cancer
    Furuya Y.
    Akakura K.
    Ito H.
    [J]. International Journal of Clinical Oncology, 2000, 5 (1) : 8 - 11
  • [6] On the clinical usefulness of the free-to-total prostate-specific antigen ratio
    Ciatto, S
    Rubeca, T
    Franceschini, R
    Trevisiol, C
    Confortini, M
    Pontenani, G
    Lombardi, C
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2006, 21 (01): : 1 - 5
  • [7] Effect of transrectal ultrasonography of the prostate on serum prostate-specific antigen levels and free/total prostate-specific antigen ratio
    Serel, TA
    Çetin, M
    Delibas, N
    Çelik, E
    Tahoglu, M
    [J]. UROLOGIA INTERNATIONALIS, 2000, 64 (01) : 24 - 26
  • [8] Utility of total prostate-specific antigen and free prostate-specific antigen index to detect prostate cancer in the asymptomatic patient
    Rivera-Sanchez, Roberto
    Parre-Mendez, Carlos
    Luisa Caballero-Juradoc, Maria
    Flores-Paz, Rocio
    [J]. ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2022, 56 (01): : 11 - 15
  • [9] Effect of prostatic biopsy on free-to-total prostate-specific antigen ratio in patients with prostate cancer
    Furuya, Y
    Akakura, K
    Ichikawa, T
    Masai, M
    Igarashi, T
    Ito, H
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2000, 7 (02) : 49 - 53
  • [10] Change in the ratio of free-to-total prostate-specific antigen during progression of advanced prostate cancer
    Tanaka, M
    Murakami, S
    Suzuki, N
    Shimazaki, J
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2000, 7 (03) : 83 - 87